Skin ⏱ Half-life: Topical application — systemic half-life not applicable

Matrixyl

Palmitoyl Pentapeptide-4 (Pal-KTTKS)

Buy at SourcePeptides →
Half-Life
Topical application — systemic half-life not applicable
Purity
≥95% (cosmetic grade)
Mol. Weight
802.05 Da
Form
White powder; formulated in serums and creams

What is Matrixyl?

Matrixyl (Palmitoyl Pentapeptide-4) is one of the most well-researched cosmetic peptides, developed by Sederma. Unlike Argireline which relaxes muscles, Matrixyl works by stimulating the skin’s own collagen-producing machinery — making it a true regenerative anti-aging ingredient rather than a cosmetic concealment.

Dosage Information (Research Use)

Topical: 2-8% concentration in formulations. Apply twice daily. Results visible in 4-8 weeks. Cosmetic ingredient — not for injection.

Reconstitution & Handling

Soluble in water. Formulate at pH 5-7 in aqueous serums or oil-in-water emulsions.

Half-Life & Pharmacokinetics

Topical application — systemic half-life not applicable

Reported Observations in Literature

Very well tolerated. No irritation or sensitization reported in clinical studies at recommended concentrations. Suitable for sensitive skin types.

Key Research References

  • Robinson LR et al. “Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin.” Int J Cosmet Sci. 2005;27:155-60

How Matrixyl Works

Matrixyl works as a matrikine — a fragment of extracellular matrix proteins that signals fibroblasts to produce new collagen, elastin, and glycosaminoglycans. The KTTKS pentapeptide is a fragment of type I collagen procollagen that activates collagen synthesis through TGF-β signaling. The palmitoyl fatty acid tail enhances skin penetration by increasing lipophilicity.

Research Applications

🔬 Anti-aging and wrinkle reduction
🔬 Collagen stimulation mechanisms
🔬 Wound healing acceleration

Research Findings

Double-blind studies show Matrixyl reduces wrinkle depth and volume by up to 45% over 4 months at 3% concentration. Stimulates type I collagen, type III collagen, and fibronectin synthesis in fibroblast cultures. The successor Matrixyl 3000 combines Pal-GHK with Pal-GQPR for enhanced effects.

Dosage & Administration

Topical: 2-8% concentration in formulations. Apply twice daily. Results visible in 4-8 weeks. Cosmetic ingredient — not for injection.

Safety & Side Effects

Very well tolerated. No irritation or sensitization reported in clinical studies at recommended concentrations. Suitable for sensitive skin types.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Pal-Lys-Thr-Thr-Lys-Ser
Molecular Weight 802.05 Da
Half-Life Topical application — systemic half-life not applicable
Purity ≥95% (cosmetic grade)
Form White powder; formulated in serums and creams
Storage Store powder at -20°C. Formulated products at room temperature.

Key Research References

  • Robinson LR et al. "Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin." Int J Cosmet Sci. 2005;27:155-60

Get Matrixyl from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
SNAP-8
Skin
Eight-amino acid peptide that reduces expression lines by inhibiting SNARE complex assembly — an enhanced successor to Argireline.
View Profile → Buy at SP →
GHK-Cu
Skin
Naturally occurring copper-binding tripeptide researched for wound healing, skin remodeling, collagen synthesis, and anti-aging applications.
View Profile → Buy at SP →
Argireline
Skin
Topical cosmetic peptide that reduces wrinkle appearance by inhibiting SNARE complex formation at the neuromuscular junction.
View Profile → Buy at SP →